尼尔塞维马布:一个审查
1Department of Pediatrics, Good Samaritan University Hospital, West Islip, New York, USA.
Pediatric allergy, immunology, and pulmonology
|March 14, 2024
概括
新的RSV预防工具为婴儿和老年人提供了希望. 长效抗体Nirsevimab推用于婴儿,而疫苗可用于老年人和孕妇.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 呼吸道同胞病毒 (RSV) 是美国婴儿住院的主要原因.
- 在所有年龄组中,RSV会导致严重的下呼吸道感染.
- 最近在2023年取得的进展引入了新的预防策略.
研究的目的:
- 审查最近FDA对新RSV预防工具的批准.
- 突出尼尔塞维玛布 (nirsevimab) 的作用,一个单克隆抗体,用于婴儿保护.
- 讨论对婴儿和有风险儿童的尼尔塞维玛布 (nirsevimab) 给药建议.
主要方法:
- 审查FDA的批准和ACIP和AAP的建议.
- 专注于nirsevimab (BeyfortusTM) 在脆弱人群中预防RSV.
- 对老年人和孕妇的疫苗批准的分析.
主要成果:
- 美国食品和药物管理局在2023年批准了三种新的RSV预防工具.
- 尼尔塞维玛 (BeyfortusTM) 已获批准用于婴儿和幼儿.
- 疫苗 (ArexvyTM和AbrysvoTM) 已批准用于60岁以上的成年人和孕妇.
结论:
- 尼尔塞维马布推给所有8个月以下的婴儿和8-19个月高危儿童使用.
- 新的RSV疫苗和单克隆抗体显著提升了预防工作.
- 这些工具旨在减少婴儿和老年人的严重RSV疾病和住院治疗.
更多相关视频
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.5K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
相关概念视频
Humoral Immune Responses
Overview
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
